• Thursday, 4 September 2014
  • Friday, 5 September 2014
  • Saturday, 6 September 2014
  • Sunday, 7 September 2014
General Session
State-of-the-Art Lecture
Symposium
Industry Symposium
Workshop
TIME
13:00
19:00
Pre-conference workshop on Clinical Trial Design in HCC
Pre-conference workshop subject to an additional registration.
To attend this workshop, full conference registration is compulsory.
TIME
08:00
09:30

ILCA Symposium 1: Emerging Concepts for Understanding Liver Cancer: Immunity, Inflammation and Cancer Stem Cells
Chairs: Xin Wei Wang, PhD (USA) and Tim Greten, MD (USA)

Cellular Plasticity in Liver Cancer
Darjus Tschaharganeh, MD (USA)

Metabolic Stress, Liver Damage and Hepatocyte Reprogramming and the Pathogenesis of HCC
Atsushi Umemura, MD, PhD (USA) on behalf of Michael Karin, PhD (USA)

The Role of Cancer Stem Cells in HCC
Taro Yamashita, MD, PhD (Japan)

Senesence, Immune Response and Hepatocarcinogenesis
Lars Zender, MD (Germany)

09:30
10:30
State-of-the-Art Lecture 1: Confounding Parameters for Survival Prediction – Impact in Clinical Management and Trial Design
Chair: Peter R. Galle, MD, PhD (Germany)
Jordi Bruix, MD (Spain)
10:30
11:00
Coffee and Networking Break
11:00
11:15
Welcome Address
Peter R. Galle, MD, PhD (Germany)
Riccardo Lencioni, MD (Italy)
Morris Sherman, MD, PhD (Canada)
11:15
12:45
General Session 1: Molecular Pathogenesis of Liver Cancer I
12:45
13:00
Session Break
13:00
14:30
Bayer Lunch Symposium
14:45
16:15
General Session 2: Molecular Pathogenesis of Liver Cancer II
16:15
16:45
Coffee and Networking Break
16:45
18:15

ILCA Symposium 2: Clinical Controversies in Liver Cancer (Pros and Cons Session)
Chairs: Morris Sherman MD, PhD (Canada) and Myron Schwartz, MD (USA)

Resection of Resectable HCCs is not Enough
Jacques Belghiti, MD (France) vs. Norihiro Kokudo, MD, PhD (Japan)

Resection Should be Performed According to BCLC
Josep Fuster, MD (Spain) vs. Ronnie Poon, MD, PhD (P.R. China)

Chemotherapy is an Option in Advanced HCC
Shukui Qin, MD (P.R. China) vs. Andrew Zhu, MD, PhD (USA)

18:15
18:45
Welcome Reception
18:45
19:45
Special Interest Group (SIG) Meetings for ILCA Members
TIME
07:30
08:30
Celsion Symposium
08:30
10:00
General Session 3: Epidemiology, Staging and Prognosis
10:00
11:00
e-Poster Viewing Tour and Networking Break
11:00
12:30
Plenary Session
Chairs: Peter R. Galle, MD, PhD (Germany), Riccardo Lencioni, MD (Italy) and Morris Sherman, MD, PhD  (Canada)
12:30
12:45
Session Break
12:45
14:00
Luncheon Workshops

Current Issues on Tumour Genomic Heterogeneity and its Implication in Clinical Practice
Jessica Zucman-Rossi, MD, PhD (France), Xin Wei Wang, PhD (USA) and Jens U. Marquardt, MD (Germany)

Immune-Pathogenesis of HCC and Therapeutic Implications
Tim Greten, MD (USA) and Robert Wiltrout, PhD (USA)

Transarterial Treatment of HCC − Differences and Similarities: North America vs. Europe vs. Asia
Riad Salem, MD (USA), Riccardo Lencioni, MD (Italy), Yasuaki Arai, MD (Japan)

Systemic Therapy for HCC – Why Do We Keep Failing?
Richard Finn, MD (USA), Tim Meyer, MD, PhD (United Kingdom) and Joong-Won Park, MD, PhD (South Korea)

Liver Transplantation for Cholangiocarcinoma: Where do we Stand and Future Directions
Pierre-Alain Clavien, MD, PhD (Switzerland), Shahid A. Khan, MD, PhD (United Kingdom)

14:00
14:15
Session Break
14:15
15:45
General Session 4: Surgery and Loco-Regional Therapy
15:45
16:45
e-Poster Viewing Tour and Networking Break
16:45
18:45
ILCA Symposium 3: Novel Opportunities for Treatment in HCC
Chairs: Peter R. Galle, MD, PhD (Germany) and Josep M. Llovet, MD (Spain/USA)

Surveillance, Treatment and Outcome of HCC in Japan
Masatoshi Kudo, MD, PhD (Japan)

HCC Risk Scores – Ready to Use in 2014?
Chien-Jen Chen, MD (Taiwan)

External Beam Radiation – An Option in HCC?
Laura Dawson, MD (Canada)

Loco-Regional Therapy: TACE or SIRT?
Bruno Sangro, MD, PhD (Spain)

Emerging Therapies in HCC
Richard Finn, MD (USA)

18:45
19:45
BTG Symposium
19:45
20:45
Special Interest Group (SIG) Meetings for ILCA Members
TIME
08:30
09:15
ILCA General Assembly
09:15
09:45
Coffee and Networking Break
09:45
10:45
State-of-the-Art Lecture 2: HCC – The African Dimension
Chair: Morris Sherman, MD, PhD (Canada)
Michael Kew, MD, PhD (South Africa)
10:45
12:15
General Session 5:  From Drivers to Trials
12:15
12:30
Closing Ceremony